
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.3722   -0.1280    0.6113 P   0  0  0  0  0  0  0  0  0  0  0  0
    0.9019   -1.5802    1.0545 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.3679    1.0954   -0.6108 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3589    0.2185   -0.2252 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9329   -0.5701    0.0667 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.4072   -0.1395   -0.4440 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7528   -2.0359    1.2752 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4747   -1.2934    0.8321 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9424   -3.4229    1.1098 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8393   -1.3171    1.7989 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1862   -4.0310    1.3622 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1078   -1.8892    1.9313 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2713   -3.2581    1.7674 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2832   -1.8972    1.2176 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0813    0.1699   -0.1396 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  5  2  0
  1  6  2  0
  2 14  1  0
  3 15  1  0
  4 15  2  0
  7  8  1  0
  7  9  2  0
  7 10  1  0
  8 14  2  0
  8 15  1  0
  9 11  1  0
 10 12  2  0
 11 13  2  0
 12 13  1  0
M  CHG  1   3  -1
M  END
>  <DRUGBANK_ID>  (1) 
DB02514

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT00995

>  <COMMON_NAME>  (1) 
(2Z)-3-{[Oxido(oxo)phosphoranyl]oxy}-2-phenylacrylate

>  <CAS_NUMBER>  (1) 
2007-07-0

$$$$
